Response Assessment in Metastatic Melanoma Treated With Ipilimumab and Bevacizumab: CT Tumor Size and Density as Markers for Response and Outcome
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-014-0040-2
Full Text
Open PDFAbstract
Available in full text
Date
November 18, 2014
Authors
Publisher
BMJ